Member Info for Energyshares

OK let’s keep the bashers away for the weekend.
Avacta pipeline
What’s everyone’s Top 3 Biggest Blockbusters to come out of this List:

My Top 3

1. AVA6000 this could explode the oncology pipeline
2. Affidx so close now if and when this launches the diagnostic pipeline has so much potential.
3. Affyxell this company alone will be worth a fortune.
(Dark Horse Astrea)

Ava6000,
AVA7500,
AVA028,
AVA7000,
AVA004
AVA027,
AVA3996
plus 4 undisclosed targets
Affidx supply World wide Gov’s ?
Bams Bruker
Elisa Abcam
New Test Mologic
Plus in house pipe line
non-COVID diagnostic tests, which include assays D-dimer,
cortisol,
vitamins D
B12
CRP
LG Chem x 8 targets
Daewoong x 2 targets
Gene & stem cell
45% ownership Affyxell
Point x 1 radiopharma drug
ADC Therapeutics x 3 targets
Moderna x 1 license
Astrea x 1
Deepverge x 1
Biokit x 1

Dirty Den took him for a walk he will be back soon.

Rolly
You were good on Grange Hill
But the best part of your career was under the bar in Eastenders.
Dirty Den taking you for a walk
Was that were you learnt to value companies.

Rolly
Oh dear your numbers, you were good at Maths in Grange Hill but you seem to gone down the nick a bit since you started knocking about with Tucker Jenkins

The numbers required by the government
Avacta are the only company that can guarantee reagent supply .

Affimers are the Holy Grail with No competition.

Massive difference between
AS leadership of Avacta he is very professional and they way he controls companies announcements is fitting to a future FTSE 100 company.

Colin King ODX on the other hand reminds me of a small start up receiving their first contract, their twitter feed is embarrassing
for a AIM company CO .
It’s like he is running Bongo Bingo.

Zen dog stick to sailing your boat
Your jokes are S4ite

Eliot Forster
Non Executive Chairman of Avacta is CO of F-Star
F Star Bio
We are a clinical-stage biopharmaceutical company with an advanced pipeline of multiple immuno-oncology programs dedicated to creating a paradigm-shift in cancer therapy.

We listed on NASDAQ in November 2020 following a business combination with Spring Bank Pharmaceuticals.

Now that could be a quick merger for a placing.

Strange RNS
News of single broker then this:

In addition to disclosure of Dr Trevor Nicholls' directorship of Oxloc Limited (as disclosed on 5 August 2013), Oxloc Limited was placed into administration in 2008 and dissolved in 2010.

Very strange to bring Dr Nicholl’s past up this far back .
Could it be a requirement for Nasdaq listing to highlight this.
Just a thought.......

It still works,
Ready for the next one........

If you can keep your shares when all about you are losing theirs and blaming it on you,   
If you can trust yourself when all the other LSE BB’s doubt you,but make allowance for their doubting too;   
If you can wait a year and not be tired by waiting,
    Or being lied about, don’t deal in lies,
Or being hated, don’t give way to hating,
    And yet don’t look too good, nor talk too wise:

If you can dream £200 ex-China and not make dreams your master;   
    If you can think—and not make thoughts on aim;   
If you can meet with Triumph and Disaster
    And treat those two impostors MB & Turtle just the same;   
If you can bear to hear the truth you’ve spoken
    Twisted by knaves to make a trap for fools,
Or watch the things you gave your life to, broken,
    And stoop and build ’em up with worn-out tools:

If you can make one heap of all your share winnings
    And risk it on one Saliva Lateral Flow,
And lose, and start again with Affidx at your beginnings
    And never breathe a word about your loss;
If you can force your heart and nerve and sinew
    To serve your turn long after they are gone,   
And so hold on when there is nothing in you
    Except the Will which says to them: ‘Hold on to your shares!’

If you can talk with Avacta BB members and keep your virtue,   
    Or walk with Kings—nor lose the common touch,
If neither foes nor loving friends can hurt you,
    If all men count with you, but none too much;
If you can fill the unforgiving minute
    With sixty seconds’ worth of distance run,   
Yours is the Earth and everything that’s in it,   
    And—which is more—you’ll be a Avacta Man, my son!

You are a Simple Simon
He was taken the pi55
:)

JRDC
You forgot to add our coffee bill. :)

Sorry I disagree,
Gov trying to clean Lateral flow reputation they want a easy quick solution.

Someone put leaflet instructions for odx test on here the other day.
If you don’t read at 10 minutes start again with another test.
This would be slaughtered in press for waste and ease of use.

Most people would do a test in morning carry on with what they were doing and check on results.
If you don’t make 10 minute time you can receive false reading.

Also Why have 2 tests one more accurate than the other, doesn’t make sense .If odx are to manufacture Affidx why take capacity away by manufacturing Mologic test ???????

Best in class with a 3p rise.
Poor MB have been waiting a year for this test.

Petros Sarantos
Head of Product Management, Diagnostics at Avacta.

Meet the team page, I’m sure he was there last week he has been removed.
But he did have a c rap photo.

They must be waiting for his new photo so we can release CE RNS :) :) :)

Astrea getting really excited about their chance to receive exclusive rights from Avacta and rightly so....

The global protein purification and isolation market size is expected to reach USD 11.2 billion by 2027.

https://www.grandviewresearch.com/press-release/global-protein-purification-isolation-market

Astrea Bioseparations starting to promote Affimers on twitter.
Join us for #BPIDigitalWeek to learn more about: ligand discovery, advantages of using synthetic ligand libraries and how @Avacta Affimer® ligand technology offers unique solutions for affinity purification.

Register: loom.ly/LHJe0y0

Abingdon advertising USA & Canada manufacturing supply,on their website interesting if AS will be using them for Affidx over there as well as here.
https://www.abingdonhealth.com/services/usa-canada/

Mologic update tweet :

To clarify, this tweet refers to the expected next steps as described in Avacta’s RNS - completing the necessary assessment of the product from our manufacturing partner Global Access Diagnostics, including stability testing, that will complete the technical file for CE marking.

Affimer description:
Affimer binders are recombinant proteins. They display the robust characteristics of high thermostability, with melting temperatures over 80 °C,resistance to extremes of pH (2–13.7), freeze-thaw cycles and lyophilisation. The low molecular weight of Affimer binders means that problems of steric hindrance, that are typically observed with antibodies, may be avoided.As they are manufactured using recombinant bacterial production processes, the batch-to-batch consistency is maintained for Affimer reagents, overcoming some of the issues of reproducibility and security of supply.

Relaxed just waiting for CE and Orders :)